PSM News
Key takeaways from PSM’s Axios event: Examining risk and regulation in the compounded GLP-1 landscape
SAFE Drugs Act sponsor Rep. Rudy Yakym (R-IN), Rep. Nikki Budzinski (D-IL), leading obesity medicine specialist Dr. Scott Kahan, and PSM Executive Director Shabbir Imber Safdar. delivered a clear message: Compounded substances are not the same as FDA-approved medications, and treating them as such undermines patients’ safety.
[...]June 29, 2026: PSM releases road map to improve patient safety amidst compounding boom
A Call to Action: Restoring and Strengthening America’s Patient Safety System presents a two pillar system for regulators and lawmakers to preserve the FDAs gold standard.
[...]Four things Congress should do for patient safety in the rest of the 119th
This post outlines practical steps Congress should take to strengthen pharmaceutical border security, reinforce regulatory oversight, and protect patients.
[...]New initiative: Best practices for online pharmacy-to-pharmacy marketplaces
PSM is seeking input on developing a set of best practices to reduce sales of counterfeit and diverted medicines on online pharmacy-to-pharmacy marketplaces.
[...]New report reveals illegal ingredients for knockoff weight loss drugs flooding into U.S. from foreign sources, endangering patient safety
The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss drugs) are flooding into the U.S. from foreign sources despite U.S. laws forbidding them from coming through the border.
[...]PSM alerts public to criminal medicine activity on gay dating apps
PSM and ADAP Advocacy launched a campaign today about the dangers of medicine diversion criminals operating on gay dating apps such as Grindr. Learn more and report the crime on our campaign page.
[...]PSM testimony: Colorado Prescription Drug Affordability Board Meeting, June 7, 2024
A Colorado board is considering setting a price limit on the medicine Stelara. This will have unintended consequences, undermining the safety of the supply chain for this medicine and limiting patient access. Learn more by reading our testimony.
[...]PSM launches social media public awareness campaign about dangers of fake Botox
PSM is launching a public awareness campaign about the dangers of fake Botox. The campaign includes a dozen slides with quotes from a fake Botox victim about her physical effects. You can view the campaign elements in the gallery below or on PSM’s instagram channel as it rolls out over the next few weeks.
[...]Colorado updates drug importation proposal, cuts list of meds by 88, adds Ozempic
Colorado’s updated Canadian drug importation application to the FDA cuts the drug list from 112 to 24 and adds Ozempic to the list of medicines it wants from Canadians.
[...]Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision
PSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
[...]